HOME >> MEDICINE >> NEWS
The Lancet Oncology (TLO)

Billions of dollars are currently being spent on the search for effective drugs that will stop disease before it happens. Advances in genetic testing are providing more opportunities to find out which diseases people are likely to be at risk of developing--but this knowledge has put huge pressure on the medical profession to come up with ways of avoiding disease altogether. This month's leading edge questions the ethical issues involved in chemoprevention and highlights the difficulties in obtaining reliable data from chemoprevention clinical trials. It concludes: "Genetic tests have created a demand for chemoprevention that is threatening to push medicine to its limits; health services could be stretched beyond capacity because they are treating healthy people as well as the sick. To stop this snowball effect it is essential that one simple idea is kept in mind: you can spend all the money in the world on preventive medicine, but when people won't even stop smoking, can it really work?"

STOMACH CANCER - THE LATEST TARGET FOR THE 'MAGIC BULLET'

Gastrointestinal stromal tumours (GISTs) are the most recent cancer type to be targeted by the most effective new drug of recent years--imatinib mesylate. Effective treatment of GISTs has been hindered in the past by their characteristic resistance to conventional chemotherapy and persistent misclassification of these tumours in clinical studies has made pre-2000 data difficult to interpret. However, it is now known that most GISTs contain a mutation in the KIT tyrosine kinase, which means they are an ideal target for imatinib. In their review, Heikki Joensuu and colleagues discuss the recent advances in understanding of these difficult-to-treat tumours and discusses the impact of imatinib on outcome for patients with GISTs. The authors conclude that imatinib "has provided physicians with a well-tolerated and highly effective therapeutic option for a disease for which no systemic therapy existed previously".
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-207-424-4949
Lancet
30-Oct-2002


Page: 1 2

Related medicine news :

1. The Lancet calls for the creation of a world institute for risk evaluation
2. The Lancet calls for creation of Intl Commission on Global Responses to Complex Emergencies
3. Majority of authors retract 1998 Lancet paper-Lancet editor points to implications
4. The Lancet Infectious Diseases (TLID)
5. The Lancet Neurology November press release
6. Lancet readers to join WHO election debate
7. The Lancet Oncology press release
8. The Lancet Neurology October press release
9. The Lancet neurology press release
10. The Lancet Neurology press release
11. The Lancet Oncology (TLO) and the Lancet Infectious Diseases (TLID)

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2019)... ... June 13, 2019 , ... ... announced that it has signed a memorandum of understanding (MOU) with MMJ International ... product MMJ-001 and MMJ-002. , MMJ BioPharma Cultivation will be supplying MMJIH with ...
(Date:6/13/2019)... (PRWEB) , ... June 13, 2019 , ... ... relief patch, announces their partnership with cannabis delivery company, Driven Deliveries, Inc., the ... Driven Deliveries, Inc., covers 93% of the population of California with overnight cannabis ...
(Date:6/13/2019)... Idaho (PRWEB) , ... June 13, 2019 , ... ... a service to everyone in healthcare, today announced that Jon Elwell, the company’s ... Board of DirectTrust™. DirectTrust is a non-profit health care industry alliance ...
(Date:6/13/2019)... ... ... The University of Pittsburgh School of Health and Rehabilitation Sciences (SHRS) today launched its ... address the growing need for professionals who can use data to improve the quality ... to bring more graduate degrees online. The Master of Science in Health Informatics program ...
(Date:6/12/2019)... ... June 12, 2019 , ... Recent research ... and dementia patients to deteriorate. , Researchers from the University of Chichester ... professional caregivers who care for people who have dementia and experienced a declining ...
Breaking Medicine News(10 mins):
(Date:6/13/2019)... ... June 13, 2019 , ... RxNT announced today that it ... records software solution . RxNT is a leader in healthcare technology solutions. This is ... from software users to highlight the best software products from North American small businesses. ...
(Date:6/13/2019)... (PRWEB) , ... June 13, 2019 , ... ... impacting social determinants of health to improve patient outcomes, recently announced the launch ... providers, payers, hospitals, and pharmacies to develop a customized, local network of community ...
(Date:6/13/2019)... ... 13, 2019 , ... Tandigm Health , a leading ... of Frank Ingari as President and Chief Operating Officer effective July 1, 2019. ... , With more than 35 years of experience serving the healthcare and information ...
Breaking Medicine Technology:
Cached News: